A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy
作者单位:Department of Oncology, St. George's University of London, London, United Kingdom[1]School of Applied Sciences, University of Northumbria, Newcastle-upon-Tyne, United Kingdom[2]Erasmus MC, Department of Urology, Josephine Nefkens Institute, P.O. Box 2040, 3000, CA Rotterdam[3]